Variables | 2003 n (%) | 2004 n (%) | 2005 n (%) | 2006 n (%) | 2007 n (%) | 2008 n (%) | 2009 n (%) | Total n |
---|---|---|---|---|---|---|---|---|
ATC Classification | ||||||||
Alimentary tract and metabolism | 6 (12.8) | 16 (11.7) | 80 (22.0) | 110 (39.0) | 70 (48.3) | 36 (26.9) | 15 (10.7) | 333 |
Blood and blood forming organs | 2 (4.3) | 3 (2.2) | 25 (6.9) | 8 (2.8) | 9 (6.2) | 7 (5.2) | 10 (7.1) | 64 |
Cardiovascular system | 11 (23.4) | 41 (29.9) | 146 (37.5) | 62 (22.0) | 32 (22.1) | 42 (31.3) | 42 (30.0) | 376 |
Dermatological | 1 (2.1) | – | 3 (0.8) | 3 (1.1) | – | – | 9 (6.4) | 16 |
Genital and urinary system and sex hormones | 1 (2.1) | 9 (6.6) | 13 (3.6) | 6 (2.1) | – | 2 (1.5) | 6 (4.3) | 37 |
Systemic hormonal preparations | 2 (4.3) | 3 (2.2) | 5 (1.4) | 2 (0.7) | – | 1 (0.7) | 1 (0.7) | 14 |
Anti-infective for systemic use | 1 (2.1) | 4 (2.9) | 6 (1.7) | 4 (1.4) | – | 3 (2.2) | 4 (2.9) | 22 |
Antineoplastic and immunomodulation agents | – | – | 2 (0.6) | 5 (1.8) | 2 (1.4) | – | 1 (0.7) | 10 |
Muscular-skeletal system | 4 (8.5) | 7 (5.1) | 8 (2.2) | 7 (2.5) | – | 6 (4.5) | 8 (5.7) | 40 |
Nervous system | 16 (34.0) | 37 (27.0) | 53 (14.6) | 59 (20.9) | 30 (20.7) | 27 (20.1) | 30 (21.4) | 252 |
Anti-parasitic products, insecticides and repellents | – | 1 (0.7) | 5 (1.4) | 5 (1.8) | – | – | – | 11 |
Respiratory system | 1 (2.1) | 10 (7.3) | 11 (3.0) | 5 (1.8) | – | 4 (3.0) | 8 (5.7) | 39 |
Sensory organs | 2 (4.3) | 6 (4.4) | 16 (4.4) | 6 (2.1) | 2 (1.4) | 6 (4.5) | 4 (2.9) | 42 |
Various | – | – | – | – | – | – | 2 (1.4) | 2 |
Total | 47 (100.0) | 137 (100.0) | 373 (100.0) | 282 (100.0) | 145 (100.0) | 134 (100.0) | 140 (100.0) | 1258 |